The secondary endpoints were the mean change from baseline in the monthly average number of migraine days during the 3-month treatment period, the proportion of patients reaching at least 50% reduction in the monthly average number of headache days of at least moderate severity during the 3-month treatment period, the mean change from baseline in the monthly average number of days of use of any acute headache medication during the 3-month treatment period, and the mean change from baseline in the number of headache days of at least moderate severity during the first month of treatment
In general, three phases of metabolic detoxification of xenobiotics have been often described in the literature
When considered clinically appropriate, they may include GLP-1based options such as semaglutide or tirzepatide as part of a personalized weight-management plan, delivered through convenient virtual care you can access from home
Mehrvarz Sarshekeh A, Xiong HQ, Iizuka K, Hochster HS, Kopetz S
Therapeutic interventions to mitigate mitochondrial dysfunction and oxidative stress-induced damage in patients with bipolar disorder
, , ,
